Pure Biologics S.A. (WSE:PUR)

Poland flag Poland · Delayed Price · Currency is PLN
6.74
+0.10 (1.51%)
Aug 14, 2025, 4:43 PM CET
1.51%
Market Cap27.10M
Revenue (ttm)n/a
Net Income (ttm)-15.80M
Shares Out4.08M
EPS (ttm)-4.34
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume47,814
Average Volume170,190
Open6.69
Previous Close6.64
Day's Range6.41 - 6.87
52-Week Range2.22 - 33.20
Beta1.14
RSI54.02
Earnings DateSep 9, 2025

About Pure Biologics

Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified apta... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 7
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.